SCHEMBL25502789

SCHEMBL25502789

CC1(C)c2ccccc2-c2ccc(-c3ccccc3Nc3ccc(-c4ccc(-c5ccccc5)c5ccccc45)cc3)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 1/20 0.37
▸ PDK2 Q15119 5/20 0.36
▸ MAPK13 O15264 1/20 0.36
▸ MAPK12 P53778 1/20 0.36
▸ MAPK11 Q15759 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ FABP3 P05413 1/20 0.35
▸ FABP4 P15090 1/20 0.35
▸ FABP5 Q01469 1/20 0.35
▸ ACP1 P24666 5/20 0.33
▸ ABCB1 P08183 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25502808 1.00 CDC25B (0.37) CDC25BPDK2MAPK13MAPK12MAPK11
SCHEMBL25125292 0.93 PDK2 (0.40) PDK2MAPK13MAPK12MAPK11MAPK14
SCHEMBL25125300 0.92 PDK2 (0.43) PDK2MAPK13MAPK12MAPK11MAPK14
SCHEMBL18916858 0.92 PDK2 (0.37) PDK2MAPK13MAPK12MAPK11MAPK14
SCHEMBL26157815 0.91 FABP3 (0.38) CDC25BPDK2FABP3FABP4FABP5
SCHEMBL26157544 0.90 BRD4 (0.35) CDC25BPDK2KDM4EMEN1GLA
SCHEMBL25125148 0.90 PDK2 (0.40) CDC25BPDK2MAPK13MAPK12MAPK11
SCHEMBL25125293 0.89 FABP3 (0.43) CDC25BPDK2FABP3FABP4FABP5
SCHEMBL18199835 0.88 PDK2 (0.45) CDC25BPDK2MAPK13MAPK12MAPK11
SCHEMBL19163603 0.88 PDK2 (0.41) CDC25BPDK2MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-01 — — US disclosed
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-01 — — US disclosed
WO-2023096210-A1 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR 덕산네오룩스 주식회사 2023-06-01 — — WO disclosed
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-05-30 — — US disclosed
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ETV6 CDC25B 1605/4885PDK2 2431/4885MAPK13 3277/4885
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof OR51E2, NFE2L2, ETV6 CDC25B 1605/4885PDK2 2431/4885MAPK13 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback